Volume 4, Issue 1, Spring 2026

Afficher Volume 4, Issue 1, Spring 2026
  • Glucagon-like Peptide-1 Medicines for Peripheral Arterial Disease in Type 2 Diabetes: Are They Ready for Prime Time? 
  • Safety of Estrogen-Based Feminizing Gender-Affirming Hormone Therapy:  A Practical Endocrine Approach to Risk Stratification and Monitoring
  • Anabolic Androgenic Steroids: No Longer on the Fringes of Endocrinology
  • To Hold or Not to Hold? Periprocedural Management of Glucagon-like Peptide-1 Receptor‑based Agonists (GLP‑1ra) in Patients with Diabetes and Obesity
  • Androgenetic Alopecia: Pathogenesis, Evaluation, 
    and Management 
Publié: 2026-05-25

Numéro complet

Articles